News & Updates
Filter by Specialty:
Omicron more stable than ancestral strain on surfaces, resistant to neutralizing mAbs
The Omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is more stable than the ancestral strain on various smooth and porous surfaces and demonstrates marked resistance to neutralizing monoclonal antibodies (mAbs), researchers from the University of Hong Kong (HKU) have reported.
Omicron more stable than ancestral strain on surfaces, resistant to neutralizing mAbs
21 Mar 2022
COVID-19 vaccine antibodies wane within 6 months in older adults
Older adults in long-term care facilities see a rapid drop in antibody titres over the first 6 months after the second dose of the BNT162b2 vaccine for the coronavirus disease 2019 (COVID-19), reports a recent study.
COVID-19 vaccine antibodies wane within 6 months in older adults
20 Mar 2022
Lower resilience tied to poorer medication adherence in glaucoma patients
The COVID-19 pandemic has worsened the adherence to ocular hypotensive medication among patients with primary open-angle glaucoma (POAG), according to a study. Such reduction is potentially driven by lower psychometric measures of resilience and more confrontational coping strategies.
Lower resilience tied to poorer medication adherence in glaucoma patients
18 Mar 2022
Booster COVID-19 vacc cuts breakthrough infection risk, particularly in individuals with no immune dysfunction
Receipt of a booster dose of the COVID-19 vaccine reduces the risk of breakthrough COVID-19 infections* compared to full vaccination only, particularly among individuals without immunosuppressed/compromised conditions (ISC), according to a US study presented at CROI 2022.
